Search | Sohomoy

Shradha Pawar added blog Health
2026-05-05 06:27:07 -

Proto Oncogene Drug Market Trends: Advances in Targeted Cancer Therapy
The Proto Oncogene Drug Market trends indicate a strong shift toward precision medicine and targeted oncology treatments. Traditional chemotherapy is being replaced by therapies that focus on specific genetic mutations responsible for cancer progression. This shift is improving treatment effectiveness while minimizing harmful side effects for patients. Another key trend is the increasing use...

0 Comments 0 Shares 88 Views

Please log in to like, share and comment!
Anjali Shinde added blog Health
2026-07-07 06:58:02 -

Targeted Radionuclide Therapy Market Analysis of Clinical Progress and Adoption
The Targeted Radionuclide Therapy Market is being revolutionized by innovations in isotope synthesis and receptor-targeted ligand development. Recent breakthroughs have allowed for the use of alpha-emitters, which deliver a more intense dose of radiation over a shorter distance than traditional beta-emitters. This technological evolution enables a higher level of potency, making it possible to...

0 Comments 0 Shares 2 Views

Please log in to like, share and comment!
Mahesh Chavan added blog Health
2025-11-10 05:42:05 -

Antibodies Market to Reach USD 693.15 Billion by 2033 | 12.4% CAGR Growth Forecast
Market Overview The global antibodies market size was valued at USD 243.73 billion in 2024 and is projected to grow from USD 271.76 billion in 2025 to reach USD 693.15 billion by 2033, growing at a CAGR of 12.4% during the forecast period (2025-2033). The global Antibodies market continues to evolve rapidly, driven by shifting consumer trends, rising...

0 Comments 0 Shares 1K Views

Please log in to like, share and comment!
Vanshika Swami added blog Health
2026-05-29 12:34:58 -

US Mantle Cell Lymphoma Therapeutics Market Outlook and Forecast 2034
The global healthcare and oncology sectors are witnessing rapid advancements in cancer therapeutics, particularly in the treatment of rare and aggressive blood cancers such as mantle cell lymphoma (MCL). Increasing awareness regarding early diagnosis, advancements in targeted therapies, and growing investments in oncology research are significantly contributing to industry expansion. The rising...

0 Comments 0 Shares 145 Views

Please log in to like, share and comment!